Neus Serrat

511 total citations
15 papers, 351 citations indexed

About

Neus Serrat is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Neus Serrat has authored 15 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Neus Serrat's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune cells in cancer (4 papers). Neus Serrat is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Immune cells in cancer (4 papers). Neus Serrat collaborates with scholars based in Spain, United States and France. Neus Serrat's co-authors include Jorge Lloberas, Antonio Celada, Andrée Yeramian, Carlos Sebastián, Manuel Modolell, Manuel Palacı́n, Luís Arpa, Joan Bertran, Maria Paola Serra and Concepció Soler and has published in prestigious journals such as Blood, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Neus Serrat

14 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neus Serrat Spain 10 172 126 97 52 30 15 351
Rosalie Joosten Netherlands 9 85 0.5× 279 2.2× 261 2.7× 29 0.6× 104 3.5× 13 528
Ling-juan Gao China 12 106 0.6× 289 2.3× 78 0.8× 16 0.3× 121 4.0× 23 457
Judith A. Horvath‐Arcidiacono United States 11 394 2.3× 120 1.0× 186 1.9× 32 0.6× 54 1.8× 14 599
Mitsuyo Yoshida Japan 12 92 0.5× 167 1.3× 121 1.2× 16 0.3× 108 3.6× 20 354
Ruizhan Tong China 11 91 0.5× 211 1.7× 203 2.1× 13 0.3× 75 2.5× 20 450
Hiroe Nakamura Japan 12 74 0.4× 182 1.4× 124 1.3× 15 0.3× 113 3.8× 29 365
Asaha Fujimoto Japan 12 72 0.4× 164 1.3× 123 1.3× 15 0.3× 108 3.6× 17 336
Katarina Mirjačić Martinović Serbia 15 599 3.5× 115 0.9× 326 3.4× 22 0.4× 46 1.5× 29 760

Countries citing papers authored by Neus Serrat

Since Specialization
Citations

This map shows the geographic impact of Neus Serrat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neus Serrat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neus Serrat more than expected).

Fields of papers citing papers by Neus Serrat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neus Serrat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neus Serrat. The network helps show where Neus Serrat may publish in the future.

Co-authorship network of co-authors of Neus Serrat

This figure shows the co-authorship network connecting the top 25 collaborators of Neus Serrat. A scholar is included among the top collaborators of Neus Serrat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neus Serrat. Neus Serrat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Serrat, Neus, Juvencio Robles, Armando López‐Guillermo, et al.. (2024). Patient-Derived Follicular Lymphoma Tumoroids: A Tool to Recapitulate Biological Features of Low and High-Grade Lymphoma. Blood. 144(Supplement 1). 1613–1613. 1 indexed citations
2.
Valero, Juan García, Ferran Nadeu, Renaud Morin, et al.. (2023). A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses. Leukemia. 37(6). 1311–1323. 17 indexed citations
3.
Valero, Juan García, Ferran Nadeu, Renaud Morin, et al.. (2022). Immunocompetent 3D Follicular Lymphoma Model: A Preclinical Tool to Design Tailored Immunotherapies. Blood. 140(Supplement 1). 9279–9280. 1 indexed citations
4.
Valero, Juan García, Ferran Nadeu, Renaud Morin, et al.. (2022). Combination of Ibrutinib and Nivolumab Overcomes Ibrutinib Resistance in a Novel Patient-Derived Mantle Cell Lymphoma 3D Model. Blood. 140(Supplement 1). 1323–1324.
5.
Valero, Juan García, Alba Matas‐Céspedes, Fabián Arenas, et al.. (2021). The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma. Leukemia. 35(9). 2635–2649. 52 indexed citations
6.
Serrat, Neus, et al.. (2021). Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention. Cancers. 13(4). 641–641. 13 indexed citations
7.
Matas‐Céspedes, Alba, Vanina Rodríguez, Cédric Rossi, et al.. (2019). Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens. Haematologica. 105(4). 1032–1041. 32 indexed citations
8.
Valero, Juan García, Alba Matas‐Céspedes, Vanina Rodríguez, et al.. (2019). DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY. Hematological Oncology. 37(S2). 151–152. 2 indexed citations
9.
10.
Pascual-García, Mónica, Cristina Bértolo, Juan C. Nieto, et al.. (2016). CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas. Human Pathology. 56. 180–188. 20 indexed citations
11.
Serrat, Neus, et al.. (2013). The Response of Secondary Genes to Lipopolysaccharides in Macrophages Depends on Histone Deacetylase and Phosphorylation of C/EBPβ. The Journal of Immunology. 192(1). 418–426. 27 indexed citations
12.
Serrat, Neus, Selma Pereira‐Lopes, Mónica Comalada, Jorge Lloberas, & Antonio Celada. (2012). Deacetylation of C/EBPβ is required for IL‐4‐induced arginase‐1 expression in murine macrophages. European Journal of Immunology. 42(11). 3028–3037. 17 indexed citations
13.
Serrat, Neus, Maria Paola Serra, Marta Barrachina, Jorge Lloberas, & Antonio Celada. (2009). The locus control region of the MHC class II promoter acts as a repressor element, the activity of which is inhibited by CIITA. Molecular Immunology. 47(4). 825–832. 6 indexed citations
14.
Sebastián, Carlos, Maria Paola Serra, Andrée Yeramian, et al.. (2008). Deacetylase Activity Is Required for STAT5-Dependent GM-CSF Functional Activity in Macrophages and Differentiation to Dendritic Cells. The Journal of Immunology. 180(9). 5898–5906. 46 indexed citations
15.
Yeramian, Andrée, Lorena Martín‐Jaular, Neus Serrat, et al.. (2006). Arginine Transport via Cationic Amino Acid Transporter 2 Plays a Critical Regulatory Role in Classical or Alternative Activation of Macrophages. The Journal of Immunology. 176(10). 5918–5924. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalie Joosten Breakdown of academic impact, for papers by Ling-juan Gao Breakdown of academic impact, for papers by Judith A. Horvath‐Arcidiacono Breakdown of academic impact, for papers by Mitsuyo Yoshida Breakdown of academic impact, for papers by Ruizhan Tong Breakdown of academic impact, for papers by Hiroe Nakamura Breakdown of academic impact, for papers by Asaha Fujimoto Breakdown of academic impact, for papers by Katarina Mirjačić Martinović
Rankless by CCL
2026